10% of Canadian Acute Beds Licensed to Improve Visibility into Patient Flow with Medworxx Bed Board

TORONTO, Dec. 21, 2011 /CNW/ - Medworxx Inc. ("Medworxx") (TSXV: MWX), a leader in clinical patient flow, compliance and education solutions, today announces an upsurge in adoption of the Medworxx Bed Board amongst the company's clients representing 30% of hospital beds in Canada.  Approximately 10% of the nation's acute beds, or 33% of Medworxx Patient Flow clients, are now licensed on the system.  Reflecting growing concerns around conserving days in Alternate Levels of Care, when patients could viably be transitioned to more appropriate settings, the upswing reflects many hospitals' demands for visibility into clinical and operational processes.

"STEGH leveraged the functionality of the Medworxx Bed Board to improve bed turnaround times, reducing Emergency Department wait times.  For the first time, everyone in our organization can determine the status of a unit or a bed with a click, "says Jen Hilt, RN, Clinical Informatics Specialist, St. Thomas Elgin General Hospital (STEGH), ON.

Newly rebranded as Medworxx Bed Board (formerly the 'Bed Optimization System'), 33% of Medworxx Patient Flow clients are now using the system to manage patient bed requirements criteria. Grand River Hospital, ON, with 600 beds, and the province of Nova Scotia with 3,000 beds are the newest additions to the Medworxx Bed Board community that also includes Fraser Health, BC and St. Michael's Hospital in Toronto, ON.  Together, Medworxx Bed Board and Medworxx Utilization Management provide hospitals with the foundation and tools to assess, analyze and advance their patient flow improvement initiatives.

"We recognize measuring for processes, as opposed to only measuring for bed capacity, is the key to tackling patient flow challenges," says Dan Matlow, President and CEO, Medworxx. "Medworxx Bed Board provides all levels of management, as well as portering and housekeeping, with a real-time snapshot of clinical status for patients."

The Medworxx Bed Board was developed in collaboration with St. Michael's Hospital, and has since been implemented at hospital and Provincial levels across Canada. Patients' needs are matched with bed costs, ultimately saving hospital resources. Combined with the actionable reports and displays, Medworxx Bed Board fills the niche of meeting multiple needs with multiple hierarchies.

Medworxx also announces that it has retained Venture Liquidity Providers Inc. ("VLP") to initiate its Market Making Service.  The Market Making Service will be undertaken by VLP through a registered broker, W.D. Latimer Co. Limited, in compliance with the guidelines of the TSX Venture Exchange. VLP is a specialized consulting firm based in Toronto providing a variety of services focused on TSX Venture Exchange-listed issuers.  In consideration for their services, Medworxx has agreed to pay VLP $5,000 per month for a period of 12 months.  The agreement may be terminated at any time by Medworxx or VLP. Medworxx and VLP act at arm's length, and VLP has no present interest, directly or indirectly, in Medworxx or its securities. The agreement is subject to regulatory approval. 

###

About Venture Liquidity Providers Inc.

Venture Liquidity Providers is a Specialized Consulting Firm based in Toronto providing a variety of services focused on TSX Venture Exchange listed stocks.  VLP's exclusive Market Making Service is provided by W.D. Latimer Co. Limited, Canada's premier Market Making Firm. For further information on VLP, contact JC Cunningham, Vice President at 416.891.4349 or email jc@ventureliquidityproviders.com.

About W.D. Latimer Co. Limited

W.D. Latimer Co. Limited is one of Toronto's most active broker-dealers. With more than 40 proprietary traders and specialists for the Toronto Stock Exchange, an institutional agency desk and private client services, W.D. Latimer Co. Limited is one of Canada's largest proprietary trading firms.  For further information on W.D Latimer Co. Limited, contact Bill Seaward, Venture Market Making Specialist at 416.707.3131 or email bill@wdlatimer.com.

About Medworxx

Medworxx delivers health information technology solutions to over 300 clients internationally; including Canada, United States and United Kingdom.  Medworxx helps hospitals meet patient flow challenges, and requirements in compliance and education.  Medworxx offers solutions in content management, learning management, policies and procedures, utilization management, bed optimization, single sign on, portal, and emergency readiness arenas.

Medworxx started business in May, 2004, in Ontario with three employees and has since grown to approximately 40 employees. Medworxx' Executive Team and Board of Directors are experienced leaders in healthcare, sales, marketing, IT development, and finance.

Medworxx current client base is distributed approximately 75% in Canada and 25% in the United States, with a growing UK presence. Medworxx Patient Flow solution currently serves over 30% of the acute care beds in Canada.

Founded in 2004, Medworxx Inc. is publicly traded on the TSX Venture Exchange: MWX.

Visit www.medworxx.com  

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

Disclaimer

This press release contains forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking statements involve known and unknown risks, uncertainties and other factors, such as competition, technological changes, the changing needs of hospitals, the financial condition of the Company's current and potential customers, foreign currency exchange rates, as well as general economic conditions, which may cause the actual results, performance or achievements of the Corporation and Medworxx to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Actual results and developments are likely to differ, and may differ materially, from those expressed or implied by the forward-looking statements contained in this press release. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.